These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 5321263

  • 1. Suppression of strontium-90-induced development of bone tumors by infection with Bacillus Calmette-Guérin (BCG).
    Nilsson A, Révész L, Stjernswärd J.
    Radiat Res; 1965 Nov; 26(3):378-82. PubMed ID: 5321263
    [No Abstract] [Full Text] [Related]

  • 2. Antigenicity of radiostrontium-induced osteosarcomas.
    Nilsson A, Révész L, Eriksson KH.
    Radiat Res; 1972 Nov; 52(2):395-408. PubMed ID: 4509166
    [No Abstract] [Full Text] [Related]

  • 3. Involvement of IFN-gamma in Bacillus Calmette-Guérin-induced but not in tumor-induced sensitization to TNF-induced lethality.
    Cauwels A, Brouckaert P, Grooten J, Huang S, Aguet M, Fiers W.
    J Immunol; 1995 Mar 15; 154(6):2753-63. PubMed ID: 7876546
    [Abstract] [Full Text] [Related]

  • 4. Influence of bacille Calmette-Guérin infection on polyoma in hamsters and mice.
    Lemonde P, Clode-Hyde M.
    Cancer Res; 1966 Apr 15; 26(4):585-9. PubMed ID: 4286877
    [No Abstract] [Full Text] [Related]

  • 5. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [Abstract] [Full Text] [Related]

  • 6. Immunoprophylaxis of methylcholanthrene-induced tumors in mice with Bacillus Calmette-Guérin and methanol-extracted residue.
    Lavrin DH, Rosenberg SA, Connor RJ, Terry WD.
    Cancer Res; 1973 Mar 15; 33(3):472-7. PubMed ID: 4570271
    [No Abstract] [Full Text] [Related]

  • 7. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.
    Bartlett GL, Zbar B, Rapp HJ.
    J Natl Cancer Inst; 1972 Jan 15; 48(1):245-57. PubMed ID: 4568964
    [No Abstract] [Full Text] [Related]

  • 8. Vaccination against strontium-90-induced bone tumors.
    Reif AE, Triest WE.
    J Natl Cancer Inst; 1983 Sep 15; 71(3):545-52. PubMed ID: 6310200
    [Abstract] [Full Text] [Related]

  • 9. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
    Shapiro A, Ratliff TL, Oakley DM, Catalona WJ.
    Cancer Res; 1983 Apr 15; 43(4):1611-5. PubMed ID: 6339040
    [Abstract] [Full Text] [Related]

  • 10. [Bone tumors induced by strontium 90].
    Graf B, Lafuma J, Parmentier C, Parmentier N.
    Bull Cancer; 1970 Apr 15; 57(3):381-96. PubMed ID: 5278284
    [No Abstract] [Full Text] [Related]

  • 11. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
    Campos MM, Henriques MG, Calixto JB.
    Br J Pharmacol; 1997 Feb 15; 120(3):502-8. PubMed ID: 9031756
    [Abstract] [Full Text] [Related]

  • 12. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.
    Zbar B, Bernstein ID, Rapp HJ.
    J Natl Cancer Inst; 1971 Apr 15; 46(4):831-9. PubMed ID: 4324814
    [No Abstract] [Full Text] [Related]

  • 13. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus.
    Vonberg RP, Mueller M, Emmendoerffer A, Freihorst J.
    Clin Exp Med; 2005 Dec 15; 5(4):177-83. PubMed ID: 16362797
    [Abstract] [Full Text] [Related]

  • 14. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T.
    Vaccine; 2008 Feb 13; 26(7):924-32. PubMed ID: 18192091
    [Abstract] [Full Text] [Related]

  • 15. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8.
    Senaldi G, Shaklee CL, Mak TW, Ulich TR.
    Cell Immunol; 1999 May 01; 193(2):155-61. PubMed ID: 10222057
    [Abstract] [Full Text] [Related]

  • 16. A revised estimate of the maximum permissible burden for Sr90. ANL-7360.
    Marinelli LD.
    ANL Rep; 1966 Jul 01; ():34-7. PubMed ID: 5302725
    [No Abstract] [Full Text] [Related]

  • 17. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I, Radzioch D, Skamene E.
    Immunology; 1994 Apr 01; 81(4):618-25. PubMed ID: 8039813
    [Abstract] [Full Text] [Related]

  • 18. [On the problem of the joint action of strontium-90 and chemical carcinogens].
    Zapol'skaia NA, Lavrent'ev LN, Fedorova AV.
    Radiobiologiia; 1967 Apr 01; 7(3):376-80. PubMed ID: 5256341
    [No Abstract] [Full Text] [Related]

  • 19. Effect of Bacillus Calmette-Guérin on the development of primary lung cancer in Syrian golden hamsters.
    Zwilling BS, Davis GW.
    Cancer Res; 1980 Oct 01; 40(10):3455-8. PubMed ID: 7002286
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.